SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Surprise, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
2
1
1
1
0
0
Revenue Growth (YoY)
100%
0%
0%
--
--
--
Cost of Revenue
0
0
0
0
0
0
Gross Profit
1
1
0
0
0
0
Selling, General & Admin
5
5
7
8
7
6
Research & Development
1
1
1
1
1
1
Operating Expenses
7
7
8
10
9
7
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
-5
-6
-7
-9
-8
-7
Income Tax Expense
--
0
--
--
--
--
Net Income
-5
-6
-7
-9
-8
-8
Net Income Growth
-17%
-14%
-22%
13%
0%
-20%
Shares Outstanding (Diluted)
4.66
0.69
0.06
0.05
0.05
0.01
Shares Change (YoY)
540%
942%
34%
0%
400%
0%
EPS (Diluted)
-1.24
-8.85
-115.09
-193.99
-165.39
-836.99
EPS Growth
-86%
-92%
-41%
17%
-80%
-17%
Free Cash Flow
-5
-6
-7
-8
-7
-7
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
50%
100%
0%
0%
0%
0%
Operating Margin
-250%
-600%
-700%
-900%
0%
0%
Profit Margin
-250%
-600%
-700%
-900%
0%
0%
Free Cash Flow Margin
-250%
-600%
-700%
-800%
0%
0%
EBITDA
-5
-6
-7
-9
-8
-7
EBITDA Margin
-250%
-600%
-700%
-900%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-5
-6
-7
-9
-8
-7
EBIT Margin
-250%
-600%
-700%
-900%
0%
0%
Effective Tax Rate
--
0%
--
--
--
--
Follow-Up Questions
What are Senestech Inc's key financial statements?
According to the latest financial statement (Form-10K), Senestech Inc has a total asset of $3, Net loss of $-6
What are the key financial ratios for SNES?
Senestech Inc's Current ratio is 0, has a Net margin is -600, sales per share of $1.43.
How is Senestech Inc's revenue broken down by segment or geography?
Senestech Inc largest revenue segment is Fertility Control, at a revenue of 1,193,000 in the most earnings release.For geography, United States is the primary market for Senestech Inc, at a revenue of 1,193,000.
Is Senestech Inc profitable?
no, according to the latest financial statements, Senestech Inc has a net loss of $-6
Does Senestech Inc have any liabilities?
no, Senestech Inc has liability of 0
How many outstanding shares for Senestech Inc?
Senestech Inc has a total outstanding shares of 1.03